Google Chrome
Safari
Firefox
Edge
Press Room
DDF - Global Drug Delivery & Formulation Summit 2025
Hovione is exhibiting at DDF Berlin, a leading 3-day summit on drug delivery, formulation and device development that attracts over 400 senior pharmaceutical leaders. At this event, top-notch experts engage in discussions on the latest advancements in the industry, presenting case studies and sharing invaluable experience.
Do not miss our Solution Spotlight Session, on June 2 (Room 4, 10:00 - 10:30 am):
“Next generation of Excipients for Proteins: enhancing stability and reducing viscosity”
The pharmaceutical industry continues to push the boundaries of innovation, particularly in the field of biologics, which now represents a significant and growing segment of therapeutic development. As these complex molecules become more prevalent, addressing formulation challenges such as stability and high viscosity becomes increasingly critical. Traditional excipients often fall short in meeting the unique demands of modern biologics, prompting the need for next-generation solutions.
Novel excipients offer a promising path forward, enabling enhanced protein stability, reduced viscosity, and improved manufacturability and delivery. With regulatory frameworks beginning to recognize the importance of excipient innovation, now is a pivotal moment for industry stakeholders to explore and implement these advancements in protein therapeutics development.
In our Solution Spotlight Session, presented by Joana Cristovão – R&D Manager – we introduce a platform of novel synthetic sugars designed to ensure more robust biopharmaceuticals. Case studies demonstrate the significant improvements these sugars provide in enhancing model proteins manufacturing processes, stability, and viscosity reduction across various applications.
Session Highlights:
- Tackling complexity in protein therapeutics: Addressing the limitations of traditional formulations for high-concentration and complex biologics.
- Next-gen excipients in action: Real-world data showing improved stability and manufacturability using novel excipients.
Speak with our experts and learn how our extensive knowledge and experience can support your project from early stages of development to commercialization.
We look forward to seeing you at DDF Berlin.
